-
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol
Spiekman, I. A. C., Geurts, B. S., Zeverijn, L. J., de Wit, G. F., van der Noort, V., Roepman, P., de Leng, W. W. J., Jansen, A. M. L., Kusters, B., Beerepoot, L. V., de Vos, F. Y. F. L., de Groot, D-J. A., de Groot, J. W. B., Hoeben, A., Buter, J., Gelderblom, H. A. J., Voest, E. E. & Verheul, H. M. W., 3 May 2024, In: oncologist. 29, 5, p. 431-440 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
KEYNOTE-412 Investigators, May 2024, In: The Lancet Oncology. 25, 5, p. 572-587 16 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer
de Roest, R. H., van der Heijden, M., Wesseling, F. W. R., de Ruiter, E. J., Heymans, M. W., Terhaard, C., Vergeer, M. R., Buter, J., Devriese, L. A., de Boer, J. P., Navran, A., Hoeben, A., Vens, C., van den Brekel, M., Brakenhoff, R. H., Leemans, C. R., Hoebers, F. & Devriese, L. I., 1 Oct 2022, In: Radiotherapy and oncology. 175, p. 112-121 10 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
